A retrospective study of treatment persistence and adherence to mirabegron versus antimuscarinics, for the treatment of overactive bladder in Spain

A retrospective study of treatment persistence and adherence to mirabegron versus antimuscarinics, for the treatment of overactive bladder in Spain

Abstract Background Persistence on-treatment with antimuscarinics in patients with overactive bladder (OAB) is reported to be sub-optimal. This retrospective, longitudinal, observational cohort study assessed treatment persistence with β3-adrenoceptor agonists (i.e. mirabegron) and antimuscarinics,...

Full description

Bibliographic Details
Main Authors: Jameel Nazir, Zalmai Hakimi, Florent Guelfucci, Amine Khemiri, Francis Fatoye, Ana María Mora Blázquez, Marta Hernández González
Format: Article
Language:English
Published: BMC 2018-09-01
Series:BMC Urology
Subjects:
Overactive bladder
Mirabegron
Antimuscarinics
Treatment persistence
Online Access:http://link.springer.com/article/10.1186/s12894-018-0390-z

Internet

http://link.springer.com/article/10.1186/s12894-018-0390-z

Similar Items